NCT00185588 2014-09-15
Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer
Stanford University
Phase 1/2 Completed
Stanford University
European Organisation for Research and Treatment of Cancer - EORTC
M.D. Anderson Cancer Center
Novartis